FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2169682004> ?p ?o ?g. }

• W2169682004 endingPage "23" @default.
• W2169682004 startingPage "18" @default.
• W2169682004 abstract "Nonsteroidal antiinflammatory drugs (NSAIDs) have considerable potential as chemopreventive agents for colorectal cancer. Recent case-control drug surveillance and large cohort studies found that patients with regular aspirin use had a reduced incidence of colorectal cancer and/or decreased death rate from this disease. Several different NSAIDs reduce formation of both colon adenomatous polyps (the precursor lesion of colon cancer) and cancers in experimental animals given known carcinogens. Perhaps most convincing are reports that the NSAID sulindac promotes regression and inhibits recurrence of adenomatous colon polyps in patients with adenomatous polyposis coli. The best characterized pharmacologic effect of the NSAIDs is their reduction of prostaglandin synthesis by inhibiting prostaglandin synthetase PGE2, which catalyzes the formation of prostaglandin precursors from arachidonic acid. Several lines of evidence are contrary to the concept that inhibition of prostaglandin synthesis is central to the NSAIDs' chemopreventive effects. Relatively high levels of prostaglandins have been reported to inhibit tumor cell growth both in vivo and in vitro, and to inhibit differentiation in some tumor cell lines. We evaluated comparative chemopreventive effects on colon tumor formation in an azoxymethane (AOM)-induced colon carcinogenesis rat model using the NSAIDs piroxicam, sulindac, and sulindac sulfone, a metabolite of sulindac which lacks the anti-prostaglandin synthetase activity typically associated with NSAID-induced gastrointestinal toxicities. The results demonstrate that sulindac sulfone, a compound lacking anti-prostaglandin synthetase activity, inhibits AOM-induced colon cancer in rats. Substantial dose-dependent reductions in both tumor burden and tumor multiplicity were observed in the sulindac sulfone-treated animals.(ABSTRACT TRUNCATED AT 250 WORDS)" @default.
• W2169682004 created "2016-06-24" @default.
• W2169682004 creator A5012051429 @default.
• W2169682004 creator A5012800731 @default.
• W2169682004 creator A5015682564 @default.
• W2169682004 creator A5016748991 @default.
• W2169682004 creator A5024842461 @default.
• W2169682004 creator A5029541691 @default.
• W2169682004 creator A5032447339 @default.
• W2169682004 creator A5044786139 @default.
• W2169682004 creator A5053283545 @default.
• W2169682004 creator A5078332522 @default.
• W2169682004 date "1995-01-01" @default.
• W2169682004 modified "2023-09-27" @default.
• W2169682004 title "Do NSAIDs exert their colon cancer chemoprevention activities through the inhibition of mucosal prostaglandin synthetase?" @default.
• W2169682004 cites W1783022590 @default.
• W2169682004 cites W1968890157 @default.
• W2169682004 cites W1972714691 @default.
• W2169682004 cites W1977125253 @default.
• W2169682004 cites W1987193104 @default.
• W2169682004 cites W1993432244 @default.
• W2169682004 cites W1995368215 @default.
• W2169682004 cites W2008649804 @default.
• W2169682004 cites W2009160843 @default.
• W2169682004 cites W2013470548 @default.
• W2169682004 cites W2018231352 @default.
• W2169682004 cites W2018537723 @default.
• W2169682004 cites W2029431152 @default.
• W2169682004 cites W2032122995 @default.
• W2169682004 cites W2038889926 @default.
• W2169682004 cites W2039601657 @default.
• W2169682004 cites W2045691345 @default.
• W2169682004 cites W2048958198 @default.
• W2169682004 cites W2059689162 @default.
• W2169682004 cites W2060137414 @default.
• W2169682004 cites W2063293439 @default.
• W2169682004 cites W2064610337 @default.
• W2169682004 cites W2065851152 @default.
• W2169682004 cites W2075484102 @default.
• W2169682004 cites W2077991158 @default.
• W2169682004 cites W2082547823 @default.
• W2169682004 cites W2095535080 @default.
• W2169682004 cites W2107067281 @default.
• W2169682004 cites W2249057184 @default.
• W2169682004 cites W2323366608 @default.
• W2169682004 cites W2330709704 @default.
• W2169682004 cites W2336215030 @default.
• W2169682004 cites W2340945640 @default.
• W2169682004 cites W2400530759 @default.
• W2169682004 doi "https://doi.org/10.1002/jcb.240590804" @default.
• W2169682004 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8538196" @default.
• W2169682004 hasPublicationYear "1995" @default.
• W2169682004 type Work @default.
• W2169682004 sameAs 2169682004 @default.
• W2169682004 citedByCount "93" @default.
• W2169682004 countsByYear W21696820042012 @default.
• W2169682004 countsByYear W21696820042013 @default.
• W2169682004 countsByYear W21696820042014 @default.
• W2169682004 countsByYear W21696820042015 @default.
• W2169682004 countsByYear W21696820042016 @default.
• W2169682004 countsByYear W21696820042017 @default.
• W2169682004 countsByYear W21696820042018 @default.
• W2169682004 countsByYear W21696820042021 @default.
• W2169682004 crossrefType "journal-article" @default.
• W2169682004 hasAuthorship W2169682004A5012051429 @default.
• W2169682004 hasAuthorship W2169682004A5012800731 @default.
• W2169682004 hasAuthorship W2169682004A5015682564 @default.
• W2169682004 hasAuthorship W2169682004A5016748991 @default.
• W2169682004 hasAuthorship W2169682004A5024842461 @default.
• W2169682004 hasAuthorship W2169682004A5029541691 @default.
• W2169682004 hasAuthorship W2169682004A5032447339 @default.
• W2169682004 hasAuthorship W2169682004A5044786139 @default.
• W2169682004 hasAuthorship W2169682004A5053283545 @default.
• W2169682004 hasAuthorship W2169682004A5078332522 @default.
• W2169682004 hasConcept C121608353 @default.
• W2169682004 hasConcept C126322002 @default.
• W2169682004 hasConcept C142724271 @default.
• W2169682004 hasConcept C204787440 @default.
• W2169682004 hasConcept C2776241388 @default.
• W2169682004 hasConcept C2777628954 @default.
• W2169682004 hasConcept C2777956040 @default.
• W2169682004 hasConcept C2778139025 @default.
• W2169682004 hasConcept C2778237340 @default.
• W2169682004 hasConcept C2778452354 @default.
• W2169682004 hasConcept C2778484676 @default.
• W2169682004 hasConcept C2779107934 @default.
• W2169682004 hasConcept C2780664492 @default.
• W2169682004 hasConcept C2780814781 @default.
• W2169682004 hasConcept C502942594 @default.
• W2169682004 hasConcept C526805850 @default.
• W2169682004 hasConcept C555283112 @default.
• W2169682004 hasConcept C71924100 @default.
• W2169682004 hasConcept C98274493 @default.
• W2169682004 hasConceptScore W2169682004C121608353 @default.
• W2169682004 hasConceptScore W2169682004C126322002 @default.
• W2169682004 hasConceptScore W2169682004C142724271 @default.
• W2169682004 hasConceptScore W2169682004C204787440 @default.
• W2169682004 hasConceptScore W2169682004C2776241388 @default.

• next